New IPO Filings & Updated Terms

A look at the IPO filings from April 12-April 19.

NEW FILINGS

Company: KCI Holdings, Inc.
Symbol: TBD
Description: KCI is the leading global medical technology company focused on advanced wound care and specialty surgical applications.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): JP Morgan, Goldman Sachs, BofA Merrill Lynch
Filed: 4-18-19
Listed Cash Raise: $100m

Company: Sonim Technologies, Inc.
Symbol: SONM
Description: They are a leading U.S. provider of ultra-rugged mobile phones and accessories designed specifically for task workers physically engaged in their work environments, often in mission-critical roles.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): Oppenheimer, Lake Street
Co-Manager: National Securities
Filed: 4-15-19
Listed Cash Raise: $57.5m

Company: ConversionPoint Holdings, Inc.
Symbol: CPTI
Description: They will be a newly-combined technology company with a mission to provide a first-party data driven, end-to-end, artificial intelligence (AI)-powered e-commerce platform not previously available to small and mid-size businesses, or SMBs.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): Oppenheimer, GMP Securities
Filed: 4-15-19
Listed Cash Raise: $40m

Company: Milestone Pharmaceuticals Inc.
Symbol: MIST
Description: They are a Phase 3 clinical-stage biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): Jefferies, Cowen, Piper Jaffray
Filed: 4-12-19
Listed Cash Raise: $86.25m

Company: South Plains Financial, Inc.
Symbol: SPFI
Description: They are a bank holding company headquartered in Lubbock, Texas, and our wholly-owned subsidiary, City Bank, is one of the largest independent banks in West Texas.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): Keefe Bruyette & Woods, Sandler O’ Neill
Filed: 4-12-19
Listed Cash Raise: $50m

Company: Cortexyme, Inc.
Symbol: CRTX
Description: They are a clinical stage biopharmaceutical company pioneering a novel disease-modifying therapeutic approach to treat what we believe to be a key underlying cause of Alzheimer’s and other degenerative diseases.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): BofA Merrill Lynch, Credit Suisse
Co-Manager: Canaccord Genuity, JMP Securities
Filed: 4-12-19
Listed Cash Raise: $86.25m

Company: Mayville Engineering Company, Inc.
Symbol: MEC
Description: MEC is a leading U.S.-based value-added manufacturing partner that provides a broad range of prototyping and tooling, production fabrication, coating, assembly and aftermarket components.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): Baird, Citigroup, Jefferies
Co-Manager(s): UBS Investment Bank, William Blair
Filed: 4-12-19
Listed Cash Raise: $100m

Company: Applied Therapeutics, Inc.
Symbol: APLT
Description: They are a clinical-stage biopharmaceutical company developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): Citigroup, Cowen, UBS Investment Bank
Co-Manager: Baird
Filed: 4-12-19
Listed Cash Raise: $86.25m

Company: NextCure, Inc.
Symbol: NXTC
Description: They are a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): Morgan Stanley, BofA Merrill Lynch, Piper Jaffray
Filed: 4-12-19
Listed Cash Raise: $86.25m

Company: Parsons Corporation
Symbol: PSN
Description: They are a leading provider of technology-driven solutions in the defense, intelligence and critical infrastructure markets.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): Goldman Sachs, BofA Merrill Lynch, Morgan Stanley
Co-Manager(s): Jefferies, Wells Fargo, Cowen, SunTrust Robinson, MUFG, Scotiabank
Filed: 4-12-19
Listed Cash Raise: $100m

UPDATED TERMS

NONE